Mitsui, Rohto to jointly buy Chinese medicine chain Eu Yan Sang
Japanese firms Mitsui and Rohto have agreed to jointly buy Eu Yan Sang International (EYS), a Singapore company that retails traditional Chinese medicines.
Stay updated with breaking news from Mitsui. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Japanese firms Mitsui and Rohto have agreed to jointly buy Eu Yan Sang International (EYS), a Singapore company that retails traditional Chinese medicines.
(RTTNews) - Mitsui & Co., Ltd. has decided to acquire shares in Eu Yan Sang International Ltd jointly with ROHTO Pharmaceutical Co. Based in Singa...
One of Singapore's oldest homegrown brands Eu Yan Sang will be acquired by Japan's Rohto Pharmaceutical and Mitsui & Co. The deal for the 144-year-old Traditional Chinese Medicine firm is valued at $800 million. Eu Yan Sang operates over 170 retail outlets and 30 TCM clinics, mainly in Singapore, Hong Kong and Malaysia
A special purpose entity will buy around 86 per cent of the TCM maker from Righteous Crane Holding. Read more at straitstimes.com.